On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A new formative study of an in-home full-color imaging scale offers a glimpse of the Foot Selfie’s next chapter—from early home plantar photography and smartphones to AI, co-creation, and ambient monitoring.
New in Diabetes Care: dropout from diabetic foot ulcer offloading trials is not random. Slower walking and depressive symptoms predict who leaves (AUC 0.81) — and a lower-burden smart boot kept people engaged. Attrition is signal, not noise.
A guest essay by Dr. Lucian Feraru. As ambient scribes and AI engines learn to write the note, summarize the chart, and flag the risk, the physician's job quietly changes — from author to auditor. Feraru argues the next real clinical skill is not generation but verification, and warns against a bargain in which the machine gets the speed, the doctor gets the liability, and the patient gets whatever slips through the gap.
A new paper in BMC Health Services Research describes how we co-created a Foot Selfie app with, not for, people living with diabetes, caregivers, and clinicians in urban Lima and semi-rural Piura, Peru. Here is how the end-users redesigned remote diabetic foot surveillance to fit the rooms where it actually happens.
A Pasadena startup lets you check your diabetes risk with a single smartphone eye photo and a few questions — no needles, no lab. The direction is right: move screening upstream, make it free, make it fast.
A new protocol paper in Sensors describes a chatbot that doses walking like a drug for patients in diabetic foot remission.
A Stanford team demonstrates that a smartphone app measuring vibration perception thresholds can detect large-fiber sensory deficits in patients with diabetes — a potential advance for accessible, patient-operated neuropathy screening.
Natalie Armstrong presents on the Food-Energy-Water nexus and the public health impacts of data center development at the NSF C2SHiP weekly ThinkTank. A framework for decision makers, hyperscalers, industry, and communities to get to yes — or no — faster.
Armstrong and Johns Hopkins' Nino Isakadze were the two awardees Armstrong is the first podiatric surgeon to be so awarded by the PhRMA Foundation
